| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/19/2006 | EP1349833B1 Indole and dihydroindole derivatives |
| 04/19/2006 | EP1317428B1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
| 04/19/2006 | EP1296959B1 Methods and compositions utilizing quinazolinones |
| 04/19/2006 | EP1296692B1 Use of a formulation made of or containing at least one dissimilated milk serum |
| 04/19/2006 | EP1294724B1 Pyrrolo¬2,3-d|pyrimidine compounds as immunosuppressive agents |
| 04/19/2006 | EP1294395B1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR |
| 04/19/2006 | EP1250350B1 Novel crystalline composites comprising phytosterols and phytostanols or derivatives thereof |
| 04/19/2006 | EP1237886B1 Meglumine salt of a specific quinolinecarboxylic acid compound active on nmda receptors |
| 04/19/2006 | EP1196167B1 Use of p38 MAPK inhibitors in the treatment of ophthalmic conditions |
| 04/19/2006 | EP1189890B1 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 04/19/2006 | EP1177176B1 Tri-aryl acid derivatives as ppar receptor ligands |
| 04/19/2006 | EP1120419B1 Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance |
| 04/19/2006 | EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments |
| 04/19/2006 | EP1039934B1 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/19/2006 | EP1003479B1 Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 04/19/2006 | EP0901474B1 Aryl pyrimidine derivatives |
| 04/19/2006 | EP0885215B1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 04/19/2006 | CN1761680A Metastin derivative and use thereof |
| 04/19/2006 | CN1761463A Method for increasing the oral bioavailability of s-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]-2-methylpropanethioate |
| 04/19/2006 | CN1761459A Blood pressure-lowering agent, vascular flexibility-improving agent and foods having these functions imparted thereto |
| 04/19/2006 | CN1759882A Chinese traditional medicine preparation for treating hemiplegia |
| 04/19/2006 | CN1759880A Prescription of drop pills for treating thrombus and invigorating pulse-beat, and preparation method |
| 04/19/2006 | CN1759863A Recipe of drop pills of corydalis and its preparation method |
| 04/19/2006 | CN1759862A Prescription of arenobufagin drop pills and preparation method |
| 04/19/2006 | CN1759857A Soft capsule of compound peony and stillbene and production technique |
| 04/19/2006 | CN1759856A Compound preparation of multi-metalloidlothioneins and intrinsic biological active matter of earthworm |
| 04/19/2006 | CN1759854A Chinese materia medica preparation for treating cardiovascular and cerebrovascular diseases, and preparation method |
| 04/19/2006 | CN1759848A Prescription of storax oil drop pills, and preparation method |
| 04/19/2006 | CN1759847A Recipe of hairy holly drop pills, and preparation method |
| 04/19/2006 | CN1759842A Clathrate of Breviscapine, medication composition of containng clathrate of Breviscapine, and preparation method |
| 04/19/2006 | CN1759839A Recipe of |
| 04/19/2006 | CN1759837A Slow release tablet of medetofazone |
| 04/19/2006 | CN1759828A Fat emulsion of biobalide B and preparation method |
| 04/19/2006 | CN1759729A Production of sanitary battercake of ginseng and preparation method |
| 04/19/2006 | CN1252074C Compound, its preparation method and its application |
| 04/19/2006 | CN1252071C Xanthine Phosphodiesterase V inhibitors |
| 04/19/2006 | CN1252067C Benzazole derivatives and their use as JNK modulators |
| 04/19/2006 | CN1252065C Cinnoline compounds |
| 04/19/2006 | CN1252057C Thiazole derivatives for treating PPAR related disorders |
| 04/19/2006 | CN1252054C Qinoline derivatives inhibiting effect of growth factors |
| 04/19/2006 | CN1252040C Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives |
| 04/19/2006 | CN1251757C Chinese herbal medicines for hypertension prevention and radical treatment |
| 04/19/2006 | CN1251742C Chinese medicine for treating angina pectoris type coronary heart disease and its prepn. process |
| 04/19/2006 | CN1251727C Traditional Chinese medicine for treating headache disease |
| 04/19/2006 | CN1251725C Quick-acting hemorrhoids ointment (suppository) |
| 04/19/2006 | CN1251720C Medicinal composition for treating coronary heart disease |
| 04/19/2006 | CN1251719C Oral taking drug for treating bleeding from internal hemorrhoid and preparation method |
| 04/19/2006 | CN1251717C Traditional Chinese medicine composition for treating coronary heart disease and angina pectoris |
| 04/19/2006 | CN1251715C Chinese traditional medicine for treating hemorrhoid bloody stool |
| 04/19/2006 | CN1251694C Chinese medicine formulation for treating upper respiratory system disease, skin infection and haemorr hoids and its preparing method |
| 04/19/2006 | CN1251693C Chinese-western medicine compound preparation and its preparing method |
| 04/19/2006 | CN1251689C Veal-blood protein-removed extract infusion and its preparation process |
| 04/19/2006 | CN1251684C Health care food for relaxing hypertension |
| 04/19/2006 | CN1251676C Phenyl xanthine derivative |
| 04/19/2006 | CN1251673C Controlled release preparation of captopril and its preparation process |
| 04/18/2006 | US7030242 Selective inhibition of aggrecanase in osteoarthritis treatment |
| 04/18/2006 | US7030238 C-nitroso compounds and use thereof |
| 04/18/2006 | US7030218 Extending ligation technique to peptides, polypeptides, other polymers and other molecules via an amide bond; used in the synthesis of optionally polymer-modified, synthetic bioactive proteins, and of pharmaceutical compositions |
| 04/18/2006 | US7030144 Central nervous system disorders |
| 04/18/2006 | US7030143 Heterocyclic compounds |
| 04/18/2006 | US7030141 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 04/18/2006 | US7030138 Benzamidine derivatives |
| 04/18/2006 | US7030135 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia |
| 04/18/2006 | US7030133 Inhibitors of formation of advanced glycation endproducts (AGEs) |
| 04/18/2006 | US7030123 Indole derivatives with vascular damaging activity |
| 04/18/2006 | US7030120 Nitrogen-containing heterocyclic compounds and benzamide compounds and drugs containing the same |
| 04/18/2006 | US7030106 Ezetimibe formulation with lactose, croscarmellose sodium, povidone, sodium lauryl sulfate, magnesium stearate and microcrystalline cellulose |
| 04/18/2006 | US7030090 Immune-modulating peptide |
| 04/18/2006 | US7029914 DNA encoding SNORF36 receptors |
| 04/18/2006 | US7029894 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 04/18/2006 | US7029877 binding protease thrombin to phosphoethanolamine binding protein |
| 04/18/2006 | US7029858 Genetic engineering; binding collagen to integrins; vaccine |
| 04/18/2006 | US7029849 Kit for use in the diagnosis of hypertension; obtain sample, determine pattern of alleles, detect preferential gene expression, preferential gene expression indicates hypertension |
| 04/18/2006 | US7029713 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same |
| 04/18/2006 | US7029654 anticoagulants either embedded in or physically linked to materials used in the manufacture of devices used in blood collection, blood circulation, and blood storage |
| 04/18/2006 | US7029652 Administering dose of antiangiogenic cyclo-arginine-glycine-aspartic acid- containing pentapeptide (cRGD pentapeptide), radioimmunotherapeutic agent (RIT), and one additional dose of cRGD pentapeptide |
| 04/18/2006 | CA2346335C Sertraline oral concentrate |
| 04/13/2006 | WO2006038738A1 Receptor function regulating agent |
| 04/13/2006 | WO2006038680A1 2-arylcarboxamide-nitrogeneous heterocycle compound |
| 04/13/2006 | WO2006037882A1 Use of vcam-1 ligands for detecting and/or treating cardiovascular diseases |
| 04/13/2006 | WO2006037771A1 Pulmonary administration of an antithrombotic compound |
| 04/13/2006 | WO2005123651A8 L-2-(α-HYDROXYPENTYL)BENZOATES, THE PREPARATION AND THE USE THEREOF |
| 04/13/2006 | WO2005105066A8 Histone deacetylases inhibitors against hyperlipidaemias, atherosclerosis, cardiovascular diseases |
| 04/13/2006 | WO2005077397A3 Methods and compositions for treating vascular diseases |
| 04/13/2006 | US20060079713 Novel salt forms of poorly soluble probucol esters and ethers |
| 04/13/2006 | US20060079707 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function |
| 04/13/2006 | US20060079688 Process for producing acid adduct salt of polyacidic base compound |
| 04/13/2006 | US20060079670 98 human secreted proteins |
| 04/13/2006 | US20060079579 Combinations of valsartan with cox-2 inhibitors |
| 04/13/2006 | US20060079563 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2006 | US20060079548 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 04/13/2006 | US20060079529 6-7-8-9-Tetrahydro-1H-pyrrolo-[3,2-h]-isoquinoline-2,3-dione-3-oxime derivatives such as 5-phenyl-6-7-8-9-tetrahydro-1H-pyrrolo-[3,2-h]-isoquinoline-2,3-dione-3-oxime; sodium channel modulators; antiischemic agents |
| 04/13/2006 | US20060079525 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 04/13/2006 | US20060079503 Thiazolidinones and the use therof as polo-like kinase inhibitors |
| 04/13/2006 | US20060079469 Anti-restenosis agent |
| 04/13/2006 | US20060079451 Heparin-binding proteins modified with sugar chains, method of producing the same and pharmaceutical compositions containing same |
| 04/13/2006 | US20060078989 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 04/13/2006 | US20060078940 21132, a human G-protein coupled receptor family member and uses therefor |
| 04/13/2006 | US20060078918 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 04/13/2006 | US20060078878 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |